Treatment of congenital syphilis.
Although penicillin remains the drug of choice for congenital syphilis, the optimal regimen has not been established. The published clinical trials were completed before the development of repository preparations such as benzathine penicillin. Consequently, current therapy must be derived from available clinical and pharmacologic data.
D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009494:Neurosyphilis / Q000151:congenital / Q000188:drug therapy; D010400:Penicillin G / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D013590:Syphilis, Congenital / Q000188:drug therapy*; D013754:Tetracyclines / Q000627:therapeutic use
D010406:Penicillins; D013754:Tetracyclines; D004917:Erythromycin; D010400:Penicillin G